Cite
Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study.
MLA
De La Mata, Nicole L., et al. “Treatment Durability and Virological Response in Treatment-Experienced HIV-Positive Patients on an Integrase Inhibitor-Based Regimen: An Australian Cohort Study.” Sexual Health (14485028), vol. 13, no. 4, July 2016, pp. 335–44. EBSCOhost, https://doi.org/10.1071/SH15210.
APA
De La Mata, N. L., Cooper, D. A., Russell, D., Smith, D., Woolley, I., Sullivan, M. O., Wright, S., & Law, M. (2016). Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study. Sexual Health (14485028), 13(4), 335–344. https://doi.org/10.1071/SH15210
Chicago
De La Mata, Nicole L., David A. Cooper, Darren Russell, Don Smith, Ian Woolley, Maree O. Sullivan, Stephen Wright, and Matthew Law. 2016. “Treatment Durability and Virological Response in Treatment-Experienced HIV-Positive Patients on an Integrase Inhibitor-Based Regimen: An Australian Cohort Study.” Sexual Health (14485028) 13 (4): 335–44. doi:10.1071/SH15210.